Free somatostatin receptor fraction predicts the antiproliferative effect of octreotide in a neuroendocrine tumor model: implications for dose optimization.

Free somatostatin receptor fraction predicts the antiproliferative effect of octreotide in a neuroendocrine tumor model: implications for dose optimization.

Item
http://www.wikidata.org/entity/Q37365221
Pharmacodynamic imaging guides dosing of a selective estrogen receptor degraderImaging of Secreted Extracellular Periostin, an Important Marker of Invasion in the Tumor Microenvironment in Esophageal Cancer.Design, construction and testing of a low-cost automated (68)Gallium-labeling synthesis unit for clinical useContinued rapid growth in (68) Ga applications: update 2013 to June 2014.Mathematical modeling reveals a critical role for cyclin D1 dynamics in phenotype switching during glioma differentiation.Optical Imaging of Mesenchymal Epithelial Transition Factor (MET) for Enhanced Detection and Characterization of Primary and Metastatic Hepatic TumorsPhage Display Selection, In Vitro Characterization, and Correlative PET Imaging of a Novel HER3 Peptide.In liver metastases from small intestinal neuroendocrine tumors, SSTR2A expression is heterogeneous.Granzyme B PET Imaging as a Predictive Biomarker of Immunotherapy Response.Somatostatin receptor type 2 as a radiotheranostic PET reporter gene for oncologic interventions.
P2860

Free somatostatin receptor fraction predicts the antiproliferative effect of octreotide in a neuroendocrine tumor model: implications for dose optimization.

Item
http://www.wikidata.org/entity/Q37365221
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Free somatostatin receptor fra ...... cations for dose optimization.
@en
Free somatostatin receptor fra ...... cations for dose optimization.
@nl
type
label
Free somatostatin receptor fra ...... cations for dose optimization.
@en
Free somatostatin receptor fra ...... cations for dose optimization.
@nl
prefLabel
Free somatostatin receptor fra ...... cations for dose optimization.
@en
Free somatostatin receptor fra ...... cations for dose optimization.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P932
P356
P1433
P1476
Free somatostatin receptor fra ...... cations for dose optimization.
@en
P2093
P2860
P304
P31
P356
10.1158/0008-5472.CAN-13-1199
P407
P433
P478
P577
P698
P932